2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92587°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
hy ¼ÒÈ­°¡ ÀߵǴ ¿ìÀ¯, ´©Àû ÆÇ¸Å·® 10¸¸ °³ µ¹ÆÄ (2025-01-24)
Åõ½æÇ÷¹À̽º ¡®È¨ ¹Ù¸®½ºÅ¸¡¯ À§ÇÑ È¨Ä«Æä¿ëǰ 3Á¾ Ãâ½Ã (2023-11-07)
Çö´ëÂ÷ Á¤¸ù±¸ ½ºÄ®·¯½ÊÀÇ 14³â... À̰ø°è, ¹®È­¿¹¼ú ºÐ¾ß ¼º°ú (2024-12-29)
°­¿øÆ¯º°ÀÚÄ¡µµ, Áö¿ªSW±â¾÷°ú µðÁöÅÐ »ê¾÷ Áß½ÉÁö·Î µµ¾à (2024-12-16)
±×¸®³Ê¸®, COP29¿¡¼­ Àúź¼Ò ³ó¡¤Ãà»ê ÇÁ·ÎÁ§Æ® ¼Ò°³ (2024-11-20)
»ï¼º½ºÅä¾î, AI ±èÄ¡³ÃÀå°í º¸»ó ÇÁ·Î¸ð¼Ç ½ÃÀÛ (2024-10-25)
¾Ë¶óµò, ±è¾Ö¶õ°ú Á¤À¯Á¤ºÎÅÍ¡¦ ÇϹݱâ Çѱ¹¹®ÇÐ ½Å°£ ÈÆÇ³ (2024-08-22)
IBK±â¾÷ÀºÇà, °³ÀÎÄ«µå ½Å»óǰ ¡®I-ALL üũīµå¡¯ Ãâ½Ã (2024-11-08)
LG Releases Preliminary Earnings for First-Quarter 2025 (2025-04-26)
±Á³×, °¡¸ÍÁ¡ ÆíÀÇ Á¦°í À§ÇØ ¡®¼­ºñ½ºÇü ¹ðÅ·¡¯ µµÀÔ (2024-10-27)
¼­¿ïÀüÀÚÅë½Å, È­À翹¹æ ¼Ö·ç¼Ç žÀç Àü±âÂ÷ ÃæÀü±â ù ÃâÇÏ (2024-12-05)
'¼±³ÑÀº' ±è³ª¿µ-À̺ê, ¡®À̹ÙÁö À½½Ä¡¯ ¸¶·ÃÇØ ½ÃºÎ¸ð´Ô ¸¸³ª (2024-12-05)
±Û·¥½º, 2025 Çѱ¹¼ÒºñÀÚ¸¸Á·Áö¼ö 1À§ Â÷Áö¡¦ 2³â ¿¬¼Ó ¿µ¿¹ (2025-01-13)
¿¡À̼ö½º, Àü¹®°¡ À§ÇÑ ±×·¡ÇÈÄ«µå 5Á¾ Ãâ½Ã (2024-02-12)
BON CHARGE Unveils First-Ever Global Red Light Therapy Trend... (2025-02-08)
¡®ÆäÀ̽º¹Ì¡¯ ÇÑÁöÇö, ¾È¹æ±ØÀå µÚÈçµç ÀüÀ²ÀÇ 60ºÐ (2024-11-23)
NIQ's Global Report Reveals Challenges and Opportunities for... (2025-04-14)
¼­ºêÄÃó öµµ ½Ã¹Ä·¹ÀÌ¼Ç RPG ¡®·¹Á¶³Í½º¡¯ PV ¿µ»ó 6Á¾ °ø°³ (2025-01-14)
2030 ¼¼´ë »ç¶û¹ÞÀº ¡®Çå¹ý Çʻ硯 (2025-01-27)
hy ¿Â¶óÀθô ¡®ÇÁ·¹µ÷¡¯ Á¤±â±¸µ¶ »ó½Â¼¼ (2025-01-27)
¶óÀÌÇÁ¸¶½ºÅÍ, ģȯ°æ ¹ÙÀÌ¿À ½Å¼ÒÀç ¹ÐÆó¿ë±â 'ºñ¿¤¶ô' (2024-04-19)
À¯·´, 2050³â±îÁö Áö¼Ó°¡´É µµ½Ã ¸ðºô¸®Æ¼ ±¸Ãà 1Á¶5õ¾ïÀ¯·Î ÇÊ... (2024-10-29)
LG CNS, Àü·Â AI ¼Ö·ç¼Ç ¡®¿¡³ÊµñÆ®¡¯ Ãâ½Ã (2024-11-24)
±â¾Æ Çã±ÇÇà ¼±ÀÓ ¿ÀÅäÄÁ¼³ÅÏÆ®, 4õ´ë ÆÇ¸Å ¡®±×·£µå ¸¶½ºÅÍ¡¯ ... (2024-11-24)
NetApp Revolutionizes Block Storage to Meet Demands of Moder... (2025-02-22)
       [ÀÌÀü][1]....[366][367][368][369][370][371][372][373][374]...[3704][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..